HeartBeam's 1st synthesized 12-lead ECG cleared by FDA, enabling cable-free at-home arrhythmia assessment with launch set for 2026.
A screenshot from a video demonstrating how to use the HeartBeam ECG device. HeartBeam (Nasdaq:BEAT) announced today that it received FDA 510(k) clearance for its 12-lead electrocardiogram (ECG) ...
1d
zSpace Showcases Major Expansion of CTE AR/VR Learning Applications at ACTE CareerTech VISION 2025
SAN JOSE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- zSpace, Inc. (NASDAQ: ZSPC), a global leader in immersive augmented reality (AR) learning ...
This strengthens NeuralCloud's expansion into the global wellness and B2B health practitioner delivery model with high-fidelity cardiac signal processing and digital health integration. Partnership ...
Abstract: Atrial fibrillation (A-Fib), a common cardiac arrhythmia, is linked to serious complications like heart failure and stroke, which early diagnosis could prevent. However, its paroxysmal and ...
Abstract: Epileptic seizure prediction holds the potential to enhance the quality of life for individuals with epilepsy by enabling the possibility of timely administration of medication and first aid ...
Wi-Fi signals bounce off humans in predictable patterns and can detect respiration and pulse, creating an invisible, ...
ADInstruments Lt educational platform provides pre designed laboratory exercises that incorporate physiological data acquisition, allowing students to perform ECG recordings while learning proper ...
Agreement expands NeuralCloud's AI-enhanced ECG signal-processing technology into veterinary health and elite equine performance marketsCommercial integration expands MaxYield™ and CardioYield™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback